BMI requirements for each GLP-1 medication Semaglutide: Wegovy and Ozempic Semaglutide operates through two branded formulations with different approved indications, and the BMI requirements vary accordingly
10.1007/s00125-009-1384-x 60
[3] For chronic weight management, Wegovy is administered at higher doses, up to 2.4 mg weekly, as an adjunct to reduced-calorie diet and increased physical activity in patients with a body mass index (BMI) of 30 kg/m or greater, or 27 kg/m or greater with at least one weight-related comorbidity
This includes reduced egg quality [19], disrupted embryo development, and impaired receptivity of the uterus [20]
My melasma spots are visibly lighter after one month
[6] Medical advisor LPC, EdD Is there a risk of weight loss drugs being abused by people with eating disorders